Belvedere Trading LLC Cue Biopharma, Inc. Transaction History

Belvedere Trading LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 20, 2022	SELL	$4.41 - $12.28 $87,401 - $243,377	-19,819 Closed	0 $0
Q4 2021 Jan 25, 2022	BUY	$10.86 - $17.85 $215,234 - $353,769	19,819 New	19,819 $178,000
Q2 2021 Jul 23, 2021	SELL	$10.9 - $14.53 $101,348 - $135,099	-9,298 Closed	0 $0
Q1 2021 Apr 27, 2021	BUY	$11.2 - $16.09 $64,052 - $92,018	5,719 Added 159.79%	9,298 $113,000
Q4 2020 Feb 10, 2021	BUY	$11.12 - $16.4 $39,798 - $58,695	3,579 New	3,579 $45,000

14.1M

14.4K

2.6K

Ticker CUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,381,700
Market Cap $38.2M
Description
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Belvedere Trading LLC with notifications on news.